Cancer patients get continued access to key drug in extension study
NCT ID NCT05112965
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This study offers continued access to the cancer drug atezolizumab for people who were already in a Roche-sponsored trial and still need treatment. About 49 participants will keep receiving their therapy while doctors monitor for serious side effects. The goal is to provide uninterrupted care until the drug is available locally.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Cancer Hospital
Beijing, 100142, China
-
Cancer Hospital of Shandong First Medical University
Jinan, Shandong, 250117, China
-
Changchun Cancer Hospital
Changchun, 130000, China
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, 150081, China
-
Henan Cancer Hospital
Zhengzhou, 450008, China
-
Hunan Cancer Hospital
Changsha, 410013, China
-
Jiangsu Cancer Hospital
Nanjing, 211100, China
-
Jilin Cancer Hospital
Changchun, 132013, China
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Peking Union Medical College Hospital
Beijing, 100730, China
-
Shanghai Chest Hospital
Shanghai, 200000, China
-
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, 310016, China
-
The 2nd Hospital of Tianjin Medical University
Tianjin, 300211, China
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, 510120, China
-
Tianjin Cancer Hospital
Tianjin, 300060, China
-
Union Hospital of Tongji Medical College, Dept. of Cancer Center
Wuhan, Hubei, 430022, China
-
Zhejiang Cancer Hospital
Zhejiang, 310022, China
Conditions
Explore the condition pages connected to this study.